Business Context and Reporting Period
This Form 8-K was filed by EFOODSAFETY.COM, INC. (noted as Pharmacyte Biotech, Inc. in metadata) on August 24, 2005. The report details the completion of a significant asset disposition involving the sale of a subsidiary.
Key Financial Metrics and Transaction Details
- Transaction Type: Sale of subsidiary "Ozone Safe Food, Inc."
- Buyer: Mark Taggatz, former President and CEO of the company.
- Consideration: 1.5 million shares of the Company's common stock and a royalty agreement.
- Debt Reduction: The shares issued were utilized to eliminate $300,000 of the company's debt.
- Royalty Structure:
- 5% of gross sales up to $20 million.
- 2.5% of gross sales between $20 million and $60 million.
- Term: Through December 31, 2008.
- Operating Expense Impact: Anticipated elimination of over $100,000 in monthly operating expenses.
Material Changes Versus Prior Period
The filing reports a material change in the company's asset base and capital structure due to the divestiture of the Ozone Safe Food, Inc. subsidiary. This transaction directly reduces the company's debt load by $300,000 and is projected to significantly lower monthly operating costs.
Outlook, Risks, and Management Commentary
Management anticipates immediate financial relief through the reduction of monthly operating expenses by over $100,000. The company retains a contingent revenue stream via the royalty agreement on future equipment sales up to $60 million. The filing does not provide specific guidance on future revenue or profit margins, nor does it detail specific risks beyond the standard contingencies of the royalty agreement.
Investor Verification Checklist
- Verify the fair market value of the 1.5 million shares issued to the former CEO.
- Confirm the exact amount of debt eliminated ($300,000) against the company's balance sheet.
- Review the attached agreement exhibit to understand the specific terms and enforcement of the royalty payments.
- Assess the accuracy of the projected $100,000 monthly operating expense reduction.
- Clarify the discrepancy between the metadata company name (Pharmacyte Biotech, Inc.) and the registrant name in the filing (EFOODSAFETY.COM, INC.).